Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M
07/04/2026 03:35
April 7 (Reuters) - Mesoblast Ltd MSB.AX: RYONCIL NET REVENUE FOR QUARTER INCREASES TO US$30.3M Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M